Boehm et al25 found that IKBKE was highly expressed in 30% of breast cancer specimens and 16.3% of breast cancer cell lines through analysis of integrative genomic approaches, thus first identifying IKBKE as a new oncogene in breast cancer. The gene discussed is IKBKE; the disease is breast carcinoma.